We have shown that two genotypes (AC and CC) of SNP A1298C might have a protective effect on CRC development that differentiates between MLH1 and MSH2 germline variant carriers, which can explain some of the previous inconsistencies in results for this SNP and risk of CRC in LS individuals. This evidence concerns the gene MSH2 and colorectal carcinoma.